Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
暂无分享,去创建一个
[1] Muhammad Usman Munir,et al. Nanomaterials Aiming to Tackle Antibiotic-Resistant Bacteria , 2022, Pharmaceutics.
[2] Bagher BabaAli,et al. Prediction of antimicrobial peptides toxicity based on their physico-chemical properties using machine learning techniques , 2021, BMC Bioinformatics.
[3] I. Whang,et al. Octopromycin: Antibacterial and antibiofilm functions of a novel peptide derived from Octopus minor against multidrug-resistant Acinetobacter baumannii. , 2021, Fish & shellfish immunology.
[4] I. Whang,et al. Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii , 2021, International journal of molecular sciences.
[5] E. Middelkoop,et al. Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs) , 2021, Frontiers in Microbiology.
[6] Muhammad Usman Munir,et al. Recent Advances in Nanotechnology-Aided Materials in Combating Microbial Resistance and Functioning as Antibiotics Substitutes , 2020, International journal of nanomedicine.
[7] Jehee Lee,et al. Molecular insight into regulation of miRNA in the spleen of zebrafish (Danio rerio) upon pathogenic Streptococcus parauberis infection. , 2020, Fish & shellfish immunology.
[8] P. Rather,et al. Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis , 2020, Frontiers in Cellular and Infection Microbiology.
[9] C. Wiart,et al. Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates , 2020, BMC complementary medicine and therapies.
[10] K. Ganbarov,et al. Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance , 2020, Infection and drug resistance.
[11] I. Whang,et al. Octominin: A Novel Synthetic Anticandidal Peptide Derived from Defense Protein of Octopus minor , 2020, Marine drugs.
[12] R. Lai,et al. The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection , 2019, Proceedings of the National Academy of Sciences.
[13] M. Yasir,et al. Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability , 2019, bioRxiv.
[14] Quan-yong He,et al. The antimicrobial peptides and their potential clinical applications. , 2019, American journal of translational research.
[15] M. Hof,et al. Effect of helical kink in antimicrobial peptides on membrane pore formation , 2019, bioRxiv.
[16] L. Chuang,et al. Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation , 2019, Molecules.
[17] Xilin Zhao,et al. Post-stress bacterial cell death mediated by reactive oxygen species , 2019, Proceedings of the National Academy of Sciences.
[18] You-Hee Cho,et al. Antibacterial strategies inspired by the oxidative stress and response networks , 2019, Journal of Microbiology.
[19] Yoonkyung Park,et al. Antibacterial and Antibiofilm Activity and Mode of Action of Magainin 2 against Drug-Resistant Acinetobacter baumannii , 2018, International journal of molecular sciences.
[20] J. Hrenović,et al. Survival of ESKAPE pathogen Acinetobacter baumannii in water of different temperatures and pH. , 2018, Water science and technology : a journal of the International Association on Water Pollution Research.
[21] W. Kamysz,et al. Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii , 2018, Probiotics and Antimicrobial Proteins.
[22] R. Mirnejad,et al. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria. , 2018, Microbial drug resistance.
[23] R. Khanum,et al. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. , 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[24] Heejun Choi,et al. Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37 , 2017, PLoS pathogens.
[25] T. Mah,et al. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. , 2017, FEMS microbiology reviews.
[26] R. Gaur. Antibiotic resistance: Alternative approaches , 2017, Indian journal of pharmacology.
[27] Shamala Devi Sekaran,et al. Intracellular Targeting Mechanisms by Antimicrobial Peptides , 2017, Antimicrobial Agents and Chemotherapy.
[28] Jehee Lee,et al. Green synthesis, physio-chemical characterization and anti-candidal function of a biocompatible chitosan gold nanocomposite as a promising antifungal therapeutic agent , 2017 .
[29] David A. Phoenix,et al. pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents , 2016, Pharmaceuticals.
[30] G. Nataraj,et al. Fluorescein diacetate vital staining for detecting viability of acid-fast bacilli in patients on antituberculosis treatment , 2016, International journal of mycobacteriology.
[31] N. Waterhouse,et al. Measuring Cell Death by Propidium Iodide Uptake and Flow Cytometry. , 2016, Cold Spring Harbor protocols.
[32] Y. Lyu,et al. Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida , 2016, Scientific Reports.
[33] H. Aghamollaei,et al. The development of antimicrobial peptides as an approach to prevention of antibiotic resistance , 2015 .
[34] W. Blalock,et al. Prohibitin 2: At a communications crossroads , 2015, IUBMB life.
[35] L. Leibovici,et al. Combination therapy for carbapenem-resistant Gram-negative bacteria. , 2014, The Journal of antimicrobial chemotherapy.
[36] G. Durn,et al. Occurrence of an Environmental Acinetobacter baumannii Strain Similar to a Clinical Isolate in Paleosol from Croatia , 2014, Applied and Environmental Microbiology.
[37] R. Hancock,et al. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. , 2013, Nature chemical biology.
[38] Yong-hui Shi,et al. The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2 , 2013, Journal of Microbiology.
[39] K. Jolliffe,et al. Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons , 2013, PloS one.
[40] S. Amyes,et al. The rise of carbapenem-resistant Acinetobacter baumannii. , 2012, Current pharmaceutical design.
[41] Qihao Zhang,et al. Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application , 2012, Peptides.
[42] Timothy R. Walsh,et al. Tackling antibiotic resistance , 2011, Nature Reviews Microbiology.
[43] Chun Xing Li,et al. Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery. , 2011, Biotechnology advances.
[44] Z. Aminzadeh,et al. Hospital Acquired Antibiotic-Resistant Acinetobacter Baumannii Infections in a 400-Bed Hospital in Tehran, Iran , 2011, International journal of preventive medicine.
[45] M. Adams,et al. Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease. , 2010, Surgical infections.
[46] Oreola Donini,et al. An anti-infective peptide that selectively modulates the innate immune response , 2007, Nature Biotechnology.
[47] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[48] S. Bishop,et al. De novo antimicrobial peptides with low mammalian cell toxicity. , 1996, Journal of medicinal chemistry.